CEF26, Influenza Virus NP (265-274) – 1 mg

Overview

CEF26, Influenza Virus NP (265-274) is a highly specific HLA-A*03 restricted epitope derived from the nucleoprotein of the influenza virus. This peptide plays a crucial role in immune response studies related to influenza infections. Utilizing CEF26 allows researchers to investigate T-cell responses, making it an essential component in vaccine development and immunological research.

Key Features

• Highly specific HLA-A*03 restricted epitope.
• Derived from influenza virus nucleoprotein (265-274).
• Ideal for T-cell immunology studies.
• Available in a convenient 1 mg format.
• Supports a variety of assays and applications.

Specifications

FAQ

What applications is CEF26 suitable for?

CEF26 can be used in T-cell response assays, vaccine development studies, and other immunological research involving influenza virus epitopes.

How should I store this peptide?

Store CEF26 at -20°C for optimal stability. Once reconstituted, it is recommended to use it promptly or store it at -80°C if not used immediately.

Can I use CEF26 in conjunction with other products?

Yes, CEF26 can be used alongside other peptides, including our PKG Substrate and Autocamtide-2to enhance your experimental outcomes.

Order your CEF26, Influenza Virus NP (265-274) today and enhance your research in immunology and vaccine development.

Related Products

• CREBtide [KRREILSRRPSYR], 5-FAM labeled

Browse more in Peptides.